SG10201508826YA - Non-replicating probiotic micro-organisms protect against upper respiratory tract infections - Google Patents

Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

Info

Publication number
SG10201508826YA
SG10201508826YA SG10201508826YA SG10201508826YA SG10201508826YA SG 10201508826Y A SG10201508826Y A SG 10201508826YA SG 10201508826Y A SG10201508826Y A SG 10201508826YA SG 10201508826Y A SG10201508826Y A SG 10201508826YA SG 10201508826Y A SG10201508826Y A SG 10201508826YA
Authority
SG
Singapore
Prior art keywords
respiratory tract
protect against
upper respiratory
tract infections
against upper
Prior art date
Application number
SG10201508826YA
Other languages
English (en)
Inventor
Valérie PETIT
Clara Lucia Garcia-Rodenas
Monique Julita
Annick Mercenier
Guénolée PRIOULT
Sophie Nutten
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43645899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201508826Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of SG10201508826YA publication Critical patent/SG10201508826YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG10201508826YA 2010-11-11 2011-11-09 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections SG10201508826YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10190819A EP2455092A1 (en) 2010-11-11 2010-11-11 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

Publications (1)

Publication Number Publication Date
SG10201508826YA true SG10201508826YA (en) 2015-11-27

Family

ID=43645899

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201508826YA SG10201508826YA (en) 2010-11-11 2011-11-09 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
SG2013035571A SG190215A1 (en) 2010-11-11 2011-11-09 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013035571A SG190215A1 (en) 2010-11-11 2011-11-09 Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

Country Status (12)

Country Link
US (2) US9370538B2 (pt)
EP (2) EP2455092A1 (pt)
CN (1) CN103547276A (pt)
AU (1) AU2011328136A1 (pt)
BR (1) BR112013011881A2 (pt)
CA (1) CA2817689A1 (pt)
CL (1) CL2013001316A1 (pt)
IL (1) IL226212A0 (pt)
MX (1) MX2013005371A (pt)
RU (1) RU2589706C2 (pt)
SG (2) SG10201508826YA (pt)
WO (1) WO2012062780A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN105722515A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
CN104957260B (zh) * 2014-03-07 2018-07-24 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
WO2015140299A1 (en) 2014-03-20 2015-09-24 Universiteit Antwerpen Oronasopharyngeal probiotics
EA035925B1 (ru) 2014-12-23 2020-09-01 4Д Фарма Рисерч Лимитед Полипептид и иммуномодуляция
EP3065748B1 (en) 2014-12-23 2017-11-22 4D Pharma Research Limited A bacteroides thetaiotaomicron strain and its use in reducing inflammation
CA2988693A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
JP6439037B2 (ja) 2015-06-15 2018-12-19 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MD3240554T2 (ro) 2015-06-15 2020-01-31 4D Pharma Res Ltd Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune
CA2994345A1 (en) * 2015-08-31 2017-03-09 Nestec S.A. Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
RS57138B1 (sr) 2015-11-20 2018-07-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
BR112018067689A2 (pt) 2016-03-04 2019-01-08 4D Pharma Plc composições compreendendo cepas bacterianas do gênero blautia para tratar a hipersensibilidade visceral
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
CN106176820A (zh) * 2016-07-12 2016-12-07 成都圣凯生物科技有限公司 一种改善上呼吸道微生态平衡的益生菌制剂及其制备方法
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018158309A1 (en) * 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
RU2768030C2 (ru) 2017-02-28 2022-03-23 Элиментари Хелт Лимитед Bifidobacterium longum, способный благоприятно модулировать иммунный ответ на респираторную вирусную инфекцию
MA48941A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
RS60910B1 (sr) 2017-06-14 2020-11-30 4D Pharma Res Ltd Kompozicije koje sadrže bakterijski soj roda megasphaera i njihove upotrebe
LT3638271T (lt) 2017-06-14 2021-01-11 4D Pharma Research Limited Kompozicijos, apimančios bakterines padermes
CN107213338A (zh) * 2017-07-19 2017-09-29 颐和益生（北京）科技有限公司 一种具有预防呼吸道感染的抗雾霾组合物、制备方法及应用
CN108004189B (zh) * 2018-01-18 2021-07-27 北京科拓恒通生物技术股份有限公司 一种复合益生乳酸菌粉剂及其制备方法与应用
JP7013419B2 (ja) * 2019-08-07 2022-02-15 日清食品ホールディングス株式会社 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用
CN113249244B (zh) * 2021-03-25 2022-10-14 上海理工大学 一种拮抗咽炎致病菌乙型溶血性链球菌的副干酪乳杆菌
CN117915934A (zh) * 2021-07-09 2024-04-19 C·德西蒙 能够通过提高HIF-1α水平来调节身体氧合的乳酸菌的种、菌株和组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69227329T3 (de) 1992-07-06 2003-01-23 Nestle Sa Milchbakterien
MXPA02003742A (es) * 1999-10-15 2003-10-14 Kampen Group Inc Van Tratamiento de tumores dermicos, verrugas e infecciones virales usando p. acnes muerto por calor.
FR2809312B1 (fr) * 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
US20050180962A1 (en) * 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
RU2258524C2 (ru) * 2003-10-23 2005-08-20 Закрытое акционерное общество "Партнер" Композиция для лечения острых респираторных заболеваний hib-этиологии у детей и способ лечения
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
WO2006124630A2 (en) * 2005-05-13 2006-11-23 New England Medical Center Hospitals, Inc. Compositions and methods for enhancing the efficacy of vaccines
AU2007216461B2 (en) 2006-02-15 2012-08-30 Société des Produits Nestlé S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
ES2650375T3 (es) 2006-10-02 2018-01-18 Dupont Nutrition Biosciences Aps Probiótcos para su uso en la reducción de síntomas de enfermedades respiratorias
WO2008053444A2 (en) * 2006-11-01 2008-05-08 The Procter & Gamble Company Treating a respiratory condition with bifidobacterium
BRPI0808052A2 (pt) * 2007-02-28 2014-06-24 Mead Johnson Nutrition Co Método para tratar ou prevenir inflamação sistêmica.
EP2227239A2 (en) * 2007-12-06 2010-09-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
ES2559008T3 (es) * 2009-05-11 2016-02-10 Nestec S.A. Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

Also Published As

Publication number Publication date
RU2013126599A (ru) 2014-12-20
WO2012062780A1 (en) 2012-05-18
AU2011328136A1 (en) 2013-05-30
CL2013001316A1 (es) 2013-10-18
US9370538B2 (en) 2016-06-21
CN103547276A (zh) 2014-01-29
US20130224253A1 (en) 2013-08-29
EP2637678A1 (en) 2013-09-18
SG190215A1 (en) 2013-06-28
US20160250265A1 (en) 2016-09-01
IL226212A0 (en) 2013-07-31
CA2817689A1 (en) 2012-05-18
EP2455092A1 (en) 2012-05-23
BR112013011881A2 (pt) 2016-11-01
MX2013005371A (es) 2013-06-28
RU2589706C2 (ru) 2016-07-10

Similar Documents

Publication Publication Date Title
IL226212A0 (en) Probiotics are non-replicating microorganisms for protection against inflammation in the upper respiratory tract
IL227193B (en) Plant extracts for the treatment and prevention of infections
PT2730564T (pt) Aminas heterocíclicas e suas utilizações
EP2542086A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE
HRP20160922T1 (hr) Oligopeptidni spojevi i njihove uporabe
SI2605757T1 (sl) Formulacije na osnovi nalbufina in njihove uporabe
HK1187527A1 (en) N-carboxyalkyl auristatins and the use thereof
SG10201503504VA (en) Novel Antimicrobial Compounds And Uses Thereof
EP2608785A4 (en) LIPOMA CYCLES AND ITS USES
ZA201304245B (en) Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
ZA201208013B (en) " selp-standing comtainer "
EP2525900A4 (en) NITROGEN PERMANENT MEMBRANES AND USES THEREOF
EP2529013A4 (en) NOVEL BETA GLUCOSIDASE AND USES THEREOF
HK1184779A1 (en) Novel compound and medical use thereof
EP2598631A4 (en) RECOMBINANT BACTERIUM AND ITS USE
GB2482320B (en) Headgear-mountable respirator
GB201007379D0 (en) Bacterial secretion
HK1209379A1 (zh) 可安裝在帽子上的呼吸機
EP2657236A4 (en) NEW 2-ALKYNYL-N9-PROPARGYLADENINE AND ITS MEDICAL USE
GB201014319D0 (en) Compounds and uses thereof
GB201002934D0 (en) You're secure
GB201010529D0 (en) "Tapease"
GB201005408D0 (en) "Speedlight"
GB201018463D0 (en) B'doosh
EP2567956A4 (en) NEW PRENYLAR CONNECTION AND USE THEREOF